Bispecific antibodies (bsAb) that target two independent epitopes or antigens have been extensively explored in translational and clinical studies since they were first developed in the 1960s. Many bsAbs are being tested in clinical trials for treating a variety of diseases, mostly cancer. Here, we provide an overview of various types of bsAbs in clinical studies and discuss their targets, safety profiles, and efficacy. We also highlight the current challenges, potential solutions, and future directions of bsAb development for cancer treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422067 | PMC |
| http://dx.doi.org/10.15252/emmm.202114291 | DOI Listing |
Publication Analysis
Top Keywords
bispecific antibodies
8
clinical studies
8
state art
4
art bispecific
4
antibodies treating
4
treating human
4
human malignancies
4
malignancies bispecific
4
antibodies bsab
4
bsab target
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!